Perspective Therapeutics (CATX) Notes Payables (2023 - 2026)
Perspective Therapeutics recorded quarterly Notes Payables of $56000.0 in Q1 2026, little changed quarter-over-quarter from $56000.0 in Q4 2025, and up 5.66% year-over-year from $53000.0 in Q1 2025.
Perspective Therapeutics' Notes Payables history runs 4 years deep, the most recent figure standing at $56000.0 for Q1 2026.
- In Q1 2026, Notes Payables rose 5.66% year-over-year to $56000.0; the TTM figure through Mar 2026 stood at $56000.0 (up 5.66% YoY), while the FY2025 annual figure was $56000.0, up 7.69% from the prior year.
- Notes Payables came in at $56000.0 for Q1 2026 at Perspective Therapeutics, roughly flat from $56000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $1.8 million in Q2 2023 to a low of $49000.0 in Q4 2023.
- A 4-year average of $316846.2 and a median of $54000.0 in 2024 frame the typical range for Notes Payables.
- Across the five-year window, Notes Payables tumbled 97.06% in 2024 and grew 7.84% in 2025, its largest moves.
- Perspective Therapeutics' Notes Payables stood at $49000.0 in 2023, then increased by 6.12% to $52000.0 in 2024, then increased by 7.69% to $56000.0 in 2025, then changed by 0.0% to $56000.0 in 2026.
- According to Business Quant data, Notes Payables over the past three periods registered $56000.0, $56000.0, and $55000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56,000.00 |
| Dec 31, 2025 | 56,000.00 |
| Sep 30, 2025 | 55,000.00 |
| Jun 30, 2025 | 54,000.00 |
| Mar 31, 2025 | 53,000.00 |
| Dec 31, 2024 | 52,000.00 |
| Sep 30, 2024 | 51,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 49,000.00 |
| Sep 30, 2023 | 1.74 Mn |
| Jun 30, 2023 | 1.77 Mn |
| Mar 31, 2023 | 80,000.00 |